Sumatriptan plus naproxen for acute migraine attacks in adults

Area of Science:

• Neurology
• Pharmacology

Background:

• Migraine is a prevalent and disabling neurological condition.
• Triptans and NSAIDs are effective abortive migraine treatments.
• Combining sumatriptan and naproxen offers a potential synergistic approach for acute migraine relief.

Purpose of the Study:

• To evaluate the efficacy and tolerability of sumatriptan plus naproxen for acute migraine treatment.
• To compare the combination therapy against placebo and other active interventions.
• To assess the impact of administration timing on treatment outcomes.

Main Methods:

• Systematic review and meta-analysis of randomized, double-blind, placebo- or active-controlled trials.
• Inclusion of studies with at least 10 participants per arm, using sumatriptan plus naproxen for migraine.
• Data extraction and analysis focusing on pain-free and headache relief responses, and adverse events.

Main Results:

• Sumatriptan plus naproxen demonstrated superior pain-free and headache relief compared to placebo.
• Combination therapy showed greater efficacy than monotherapy with sumatriptan or naproxen alone.
• Early treatment of mild migraine pain resulted in significantly better outcomes than treating moderate or severe pain.

Conclusions:

• Sumatriptan plus naproxen is an effective acute treatment for migraine headaches.
• The combination offers benefits over individual components, though the added benefit over sumatriptan alone is modest.
• Adverse events were more frequent with combination therapy and sumatriptan alone compared to placebo or naproxen alone.